Feltquate David 4
4 · iTeos Therapeutics, Inc. · Filed Dec 6, 2024
Insider Transaction Report
Form 4
Feltquate David
Chief Medical Officer
Transactions
- Award
Common Stock
2024-12-06+47,000→ 47,000 total
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. All of the shares of common stock underlying such RSUs will vest on December 6, 2026, subject to the Reporting Person's continued service to the Issuer.